| Ning Sun, FNP-BC | |
|
4144 Clemson Blvd, Anderson, SC 29621-1108 | |
| (864) 224-9598 | |
| Not Available |
| Full Name | Ning Sun |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 4144 Clemson Blvd, Anderson, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003340977 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 20916 (South Carolina) | Primary |
| Entity Name | Calvin Don Bryant |
|---|---|
| Entity Type | Practitioner - Family Practice |
| Entity Identifiers | NPI Number: 1578590790 PECOS PAC ID: 2163565359 Enrollment ID: I20100210000713 |
News Archive
A new interactive graphic developed by UK researchers and published by The BMJ today will help people decide what to do in everyday situations to protect themselves, and others, from covid-19.
In this Hill opinion piece, John Castellani, CEO and president of the Pharmaceutical Research and Manufacturers of America, writes, "Over the past three decades, more than 30 treatments have been approved to treat HIV/AIDS," but he adds, "While this is remarkable progress, it's not enough."
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
FDA and Congress "should protect physicians' and patients' right" to use FDA-approved drugs for off-label uses "and for the first time allow drugmakers to promote off-label uses that prove beneficial," Richard Epstein, a law professor at the University of Chicago and a senior fellow at the Hoover Institution, writes in a Wall Street Journal opinion piece. He continues, "Right now these drugs provide immense lifesaving opportunities for many sick patients, particularly those threatened by cancer."
A new study published in The Journal of Physiology has shown that misfolded protein build-up in the gut could contribute to the development of Alzheimer's-like symptoms in mice.
› Verified 6 days ago
| Entity Name | Trinity Family Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700349784 PECOS PAC ID: 3577897578 Enrollment ID: O20190625002807 |
News Archive
A new interactive graphic developed by UK researchers and published by The BMJ today will help people decide what to do in everyday situations to protect themselves, and others, from covid-19.
In this Hill opinion piece, John Castellani, CEO and president of the Pharmaceutical Research and Manufacturers of America, writes, "Over the past three decades, more than 30 treatments have been approved to treat HIV/AIDS," but he adds, "While this is remarkable progress, it's not enough."
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
FDA and Congress "should protect physicians' and patients' right" to use FDA-approved drugs for off-label uses "and for the first time allow drugmakers to promote off-label uses that prove beneficial," Richard Epstein, a law professor at the University of Chicago and a senior fellow at the Hoover Institution, writes in a Wall Street Journal opinion piece. He continues, "Right now these drugs provide immense lifesaving opportunities for many sick patients, particularly those threatened by cancer."
A new study published in The Journal of Physiology has shown that misfolded protein build-up in the gut could contribute to the development of Alzheimer's-like symptoms in mice.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ning Sun, FNP-BC 4144 Clemson Blvd, Anderson, SC 29621-1108 Ph: (864) 224-9598 | Ning Sun, FNP-BC 4144 Clemson Blvd, Anderson, SC 29621-1108 Ph: (864) 224-9598 |
News Archive
A new interactive graphic developed by UK researchers and published by The BMJ today will help people decide what to do in everyday situations to protect themselves, and others, from covid-19.
In this Hill opinion piece, John Castellani, CEO and president of the Pharmaceutical Research and Manufacturers of America, writes, "Over the past three decades, more than 30 treatments have been approved to treat HIV/AIDS," but he adds, "While this is remarkable progress, it's not enough."
Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.
FDA and Congress "should protect physicians' and patients' right" to use FDA-approved drugs for off-label uses "and for the first time allow drugmakers to promote off-label uses that prove beneficial," Richard Epstein, a law professor at the University of Chicago and a senior fellow at the Hoover Institution, writes in a Wall Street Journal opinion piece. He continues, "Right now these drugs provide immense lifesaving opportunities for many sick patients, particularly those threatened by cancer."
A new study published in The Journal of Physiology has shown that misfolded protein build-up in the gut could contribute to the development of Alzheimer's-like symptoms in mice.
› Verified 6 days ago
Elizabeth Anne Stuart Whitman, FNP-BC, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 N Fant St, Anderson, SC 29621 Phone: 864-512-2000 | |
Jennifer P Arnett, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Anderson, SC 29621 Phone: 864-512-1000 | |
Lacey Wilbanks, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 108 Montgomery Dr, Anderson, SC 29621 Phone: 864-225-5597 | |
Sarah Browne Long, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Ste 3850, Anderson, SC 29621 Phone: 864-225-5667 Fax: 864-716-6158 | |
Cynthia Marie Petermann, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2001 E Greenville St, Anderson, SC 29621 Phone: 864-332-3098 Fax: 855-232-3959 | |
Mrs. Jennifer Lingerfelt, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4120 Highway 24, Anderson, SC 29626 Phone: 864-224-4003 |